Takehiro Sugiyama, MD, MSHS; Yusuke Tsugawa, MD, MPH; Chi-Hong Tseng, PhD; et al.
free access
JAMA Intern Med. 2014;174(7):1038-1045. doi:10.1001/jamainternmed.2014.1927
Sugiyama and colleagues examine the difference in the temporal trends of caloric and fat intake between statin users and nonusers among US adults.
-
Editor's Note
Statins and Weight Gain
Rita F. Redberg, MD, MSc
Wei Bao, MD, PhD; Deirdre K. Tobias, ScD; Katherine Bowers, PhD; et al.
free access
JAMA Intern Med. 2014;174(7):1047-1055. doi:10.1001/jamainternmed.2014.1795
Bao et al examine the role of physical activity and television watching and other sedentary behaviors, and changes in these behaviors in the progression from gestational diabetes mellitus to type 2 diabetes mellitus. Hedderson and Ferrara provide an Invited Commentary.
Hadine Joffe, MD, MSc; Katherine A. Guthrie, PhD; Andrea Z. LaCroix, PhD; et al.
free access
JAMA Intern Med. 2014;174(7):1058-1066. doi:10.1001/jamainternmed.2014.1891
Joffe et al determine the efficacy and tolerability of low-dose oral 17β-estradiol and low-dose venlafaxine extended release in alleviating vasomotor symptoms. The primary outcome was the mean daily frequency of vasomotor symptoms after 8 weeks of treatment among 339 perimenopausal and postmenopausal women with at least 2 bothersome symptoms per day.
Less Is More
Aaron L. Schwartz, BA; Bruce E. Landon, MD, MBA; Adam G. Elshaug, PhD, MPH; et al.
free access
JAMA Intern Med. 2014;174(7):1067-1076. doi:10.1001/jamainternmed.2014.1541
Schwartz et al develop claims-based measures of low-value services, examine service use (and associated spending) detected by these measures in Medicare, and determine whether patterns of use are related across different types of low-value services. See also the editor’s note by Katz et al.
-
Editor's Note
Developing Methods for Less Is More
Mitchell H. Katz, MD; Deborah Grady, MD, MPH; Rita F. Redberg, MD, MSc
Richard D. Semba, MD, MPH; Luigi Ferrucci, MD, PhD; Benedetta Bartali, PhD; et al.
free access
JAMA Intern Med. 2014;174(7):1077-1084. doi:10.1001/jamainternmed.2014.1582
Semba and colleagues set out to determine whether resveratrol levels achieved with diet are associated with inflammation, cancer, cardiovascular disease, and mortality in humans.
Catherine L. Auriemma, MD; Christina A. Nguyen; Rachel Bronheim; et al.
free access
JAMA Intern Med. 2014;174(7):1085-1092. doi:10.1001/jamainternmed.2014.1183
Auriemma and coauthors systematically evaluate the evidence on the stability of end-of-life preferences over time and with changes in health status.
-
Invited Commentary
What Should Be the Goal of Advance Care Planning?
Yael Schenker, MD, MAS; Douglas B. White, MD, MAS; Robert M. Arnold, MD
Aaron L. Leppin, MD; Michael R. Gionfriddo, PharmD; Maya Kessler, MD; et al.
free access
JAMA Intern Med. 2014;174(7):1095-1107. doi:10.1001/jamainternmed.2014.1608
Leppin et al synthesize the evidence of the efficacy of interventions to reduce early hospital readmissions and identify intervention features—including their impact on treatment burden and on patients’ capacity to enact postdischarge self-care—that might explain their varying effects.
Hon-Yen Wu, MD; Yu-Sen Peng, MD, PhD; Chih-Kang Chiang, MD, PhD; et al.
free access
JAMA Intern Med. 2014;174(7):1108-1115. doi:10.1001/jamainternmed.2014.1363
Wu et al compare the diagnostic performance of the UAC vs the ACR in random urine samples for microalbuminuria screening among patients with DM. A literature search identified clinical studies assessing the UAC or the ACR using a urinary albumin excretion rate of 30 to 300 mg/d in 24-hour timed urine collections as the criterion standard.
Kasia J. Lipska, MD, MHS; Joseph S. Ross, MD; Yun Wang, PhD; et al.
free access
JAMA Intern Med. 2014;174(7):1116-1124. doi:10.1001/jamainternmed.2014.1824
Lipska and coauthors characterize changes in hyperglycemia and hypoglycemia hospitalization rates and subsequent mortality and readmission rates among older adults in the United States over a 12-year period and compare these results according to age, sex, and race.
Douglas C. Bauer, MD; Ann Schwartz, PhD; Lisa Palermo, MA, MS; et al.
free access
JAMA Intern Med. 2014;174(7):1126-1134. doi:10.1001/jamainternmed.2014.1232
Bauer et al test methods of predicting fracture risk among women who have discontinued alendronate therapy after 4 to 5 years of treatment.
Amanda L. Beaudoin, DVM, PhD; Lauren Torso, MPH, CIC; Katherine Richards, MPH; et al.
free access
JAMA Intern Med. 2014;174(7):1136-1142. doi:10.1001/jamainternmed.2014.1875
Beaudoin et al describe an outbreak of severe group A Streptococcus infections among persons undergoing tumescent liposuction between July 1 and September 14, 2012, at 2 outpatient cosmetic surgery facilities (one in Maryland and the other in Pennsylvania) not subject to state or federal regulation. See the invited commentary by Morgan and Harris.
-
Invited Commentary
The Gap in Patient Protection for Outpatient Cosmetic Surgery
Daniel J. Morgan, MD, MS; Anthony D. Harris, MD, MPH
Thomas C. Keyserling, MD, MPH; Stacey L. Sheridan, MD, MPH; Lindy B. Draeger, MPH; et al.
free access
JAMA Intern Med. 2014;174(7):1144-1157. doi:10.1001/jamainternmed.2014.1984
Keyserling and colleagues assess the effectiveness, acceptability, and cost-effectiveness of a combined lifestyle and medication intervention to reduce coronary heart disease risk offered in counselor-based and web-based formats. In their related Invited Commentary, Moin and Mangione expand on the topic.
Boulos S. Nassar, MD, MPH; Mary S. Vaughan-Sarrazin, PhD; Lan Jiang, MS; et al.
free access
JAMA Intern Med. 2014;174(7):1160-1167. doi:10.1001/jamainternmed.2014.1503
Nassar and colleagues examine the impact of ICU TM on mortality rates and length of stay in an integrated health care system. See also the invited commentary by Wilcox and Wiener-Kronish.